News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Rizine Mzikamanda: It is always intriguing and inspirational hearing and learning from others what work they are doing for Childhood Cancer
Photo taken from Rizine Mzikamanda/LinkedIn
Oct 26, 2023, 08:59

Rizine Mzikamanda: It is always intriguing and inspirational hearing and learning from others what work they are doing for Childhood Cancer

Rizine Mzikamanda, Pediatric Hematologist-Oncologist at Global HOPE Malawi, recently shared on LinkedIn:

“Recently attended the International Society of Paediatrics Oncology – SIOP 2023 congress in Ottawa, Canada. It is always intriguing and inspirational hearing and learning from others what work they are doing for Childhood Cancer. I had the opportunity to chair a session on nutrition in global oncology. And of course, I did a 5k run on a cold Ottawa morning. Looking forward to using the knowledge gained and next year’s congress!”

Rizine Mzikamanda: It is always intriguing and inspirational hearing and learning from others what work they are doing for Childhood Cancer

Source: Rizine Mzikamanda/LinkedIn

Childhood Cancer LinkedIn OncoDaily Oncology Rizine Mzikamanda SIOP 2023
Special Coverage
Blog
Nov 13, 2024, 11:25
Some information you should know about lung cancer - American Cancer Society
Insight
Nov 13, 2024, 11:10
Myeloma Paper of the Day, November 13th, suggested by Robert Orlowski
Blog
Nov 13, 2024, 11:01
LGCW2024 session on Galvanising African cancer research building a strong cancer workforce - AORTIC- Africa
Blog
Nov 13, 2024, 10:59
Bernard Fox received SITC lifetime achievement award
Blog
Nov 13, 2024, 10:54
Hear Her campaign Increasing awareness about lung cancer in women
Blog
Nov 13, 2024, 10:52
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Blog
Nov 13, 2024, 10:47
FDA approves obecabtagene autoleucel for relapsed or refractory B-cell precursor ALL
Blog
Nov 13, 2024, 10:45
OncoInfluencers to Follow on Social Media: Dr. Nitin Jain
Insight
Nov 13, 2024, 10:37
UCLA: Combination approach shows promise for treating rare, aggressive cancers
Opinion
Nov 13, 2024, 10:32
The 6th Biennial Miami Epigenetics and Cancer Symposium to be held in Sylvester Comprehensive Cancer Center
Blog
Nov 13, 2024, 10:16
Highlights from IU Simon Comprehensive Cancer Center’s End Lung Cancer Now Gathering - Hoosier Cancer Research Network
Blog
Nov 13, 2024, 10:06
A first-in-class Antibody Drug Conjugate that works by directly stimulating the immune system